about
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 yearsEstimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling studyA pilot study of host genetic variants associated with influenza-associated deaths among children and young adultsCan we "hedge" against the development of antiviral resistance among pandemic influenza viruses?Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communitiesMortality associated with influenza and respiratory syncytial virus in the United StatesEpidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness.Trends in mortality from respiratory disease in Latin America since 1998 and the impact of the 2009 influenza pandemic.Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza survFurther evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic.A national survey of the Infectious Diseases Society of America Emerging Infections Network concerning neuraminidase inhibitor prescription practices and pandemic influenza preparations.Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease.Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?Household responses to school closure resulting from outbreak of influenza B, North Carolina.Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States.Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial.Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections.Estimates of the impact of a future influenza pandemic in China.Estimating age-specific influenza-related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN.Emergency department visits for influenza A(H1N1)pdm09, Davidson County, Tennessee, USAEvaluation of obesity as an independent risk factor for medically attended laboratory-confirmed influenza.Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine.Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.Innate immune function and mortality in critically ill children with influenza: a multicenter studyEffectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine.A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.Household economic impact and attitudes toward school closures in two cities in Argentina during the 2009 influenza A (H1N1) pandemic.Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia.Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China.Time-series analyses of count data to estimate the burden of seasonal infectious diseases.Development and estimation of a pediatric chronic disease score using automated pharmacy data.Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysisVariation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose.Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study.Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends
P50
Q28250772-7711FC5D-7AFB-4FD7-9FF8-98726CFE9F84Q28269717-DF5C8A05-EE10-4FA9-A281-EFD41332D8E4Q28382803-E1DAFE02-04F8-46F3-AAD0-F747A0F6F999Q28475628-89BD6AA6-AC59-4D59-9756-EA8BAC3544E1Q28741469-E0269457-F7BC-476A-BFB0-6192A5CCA504Q29615578-9E9F48EE-8899-4F6F-8CF2-0A894A4B887AQ30230205-D9F21125-D9CA-471C-B56D-CE087D878DD8Q30351876-E2EF0B27-FF43-43B1-BB30-41D6419260F5Q30351995-1F5B693F-B58F-4DEB-B69B-53C695EFDAB4Q30352932-F612B281-9A5B-4305-81B2-78ED7948DE76Q30353185-3BB7486A-15D6-4374-A1B1-1D77FB75D56EQ30355467-A5EF00E1-113A-4FDF-8E61-BE62AE7CD937Q30358746-7EC4ADC4-7308-49B6-A26F-7A038EFF5817Q30367464-A83814A6-DE7B-491F-A2BB-9B06E78B7B56Q30370428-0EDB78D2-E4AF-48F3-9A90-E65EB4D1614AQ30373099-95D689E4-A00B-4678-85A7-A67AA413C962Q30383529-AFE45348-5BAF-4890-AA42-D0619567AB4BQ30384649-A0106809-0502-498C-9D7F-7D514B1E81CCQ30393399-FC3B5AFA-7977-4542-9AEA-963C315A5E91Q30401469-6E239811-5807-40BC-A797-1E34FB566294Q30413451-829CA501-A161-4ECA-805F-09F7FBB28D69Q30415598-266E9CFB-54AC-4AD4-B75F-D6D53C26BAE8Q30416732-B130C0AE-DC59-4AA7-BBF2-A40D17D4BDD9Q30416977-8BD798B9-24BA-4CC2-8E6A-C39A7FF908C6Q30417851-83E4835B-3BB8-42BC-A634-34916FC497BDQ30418318-5EA6F090-4EF1-4253-BD17-6430382515E3Q30419896-1BBA64D4-0F9E-48C2-B87E-946789E191F5Q30420010-7ED76418-63C3-43F0-9BB8-02CEC2353FDCQ30423248-033D4B55-B035-4F47-B922-D3EB2D193FCBQ30423966-F8553BCC-B031-48DA-88A0-14B2B850FA11Q30425723-B62FE1A1-23DA-404B-B998-38A7E3F78E6DQ30426206-1B3C985C-AE3F-4BDC-A3BC-F7791795C915Q30430391-1DFAFF3A-4ABC-4ADA-A186-7750BB986B8BQ30572080-71A26AD6-4792-4A16-B494-85D82269277AQ30581755-8C99B6BE-6F46-4744-9C45-66A085494652Q30891396-847FCFB0-D4F7-41C8-82D0-300A4C0E88BBQ33263447-95101AFF-ABE5-4EB7-A7C7-654FC7798A62Q33554684-EE339F07-218D-4EBD-8A8C-0065EA7D6B2EQ33630054-196DB2F0-FF55-4143-99C8-F6D8AD9F02BDQ33893785-76EF36D5-A345-4686-9B70-53CB311D9FC7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David K. Shay
@ast
David K. Shay
@en
David K. Shay
@es
David K. Shay
@sl
type
label
David K. Shay
@ast
David K. Shay
@en
David K. Shay
@es
David K. Shay
@sl
prefLabel
David K. Shay
@ast
David K. Shay
@en
David K. Shay
@es
David K. Shay
@sl
P106
P1153
7003795558
P21
P31
P496
0000-0001-9619-4820